Trial Profile
Study of licarbazepine in the treatment of manic episodes of bipolar disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Mar 2017
Price :
$35
*
At a glance
- Drugs Licarbazepine (Primary)
- Indications Bipolar I disorders
- Focus Registrational; Therapeutic Use
- Sponsors Novartis
- 09 Oct 2005 New trial record.